戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 are similar to those of a variety of chronic renal disorders.
2  of medical conditions, most notably bladder/renal disorders.
3 lomeruli (AG) have been described in several renal disorders.
4 thophysiological factors common to different renal disorders.
5 ed in the pathogenesis of cardiovascular and renal disorders.
6 711 in the therapy of the cardiovascular and renal disorders associated with aging, diabetes, and hyp
7 nd that PARS inhibitors may be beneficial in renal disorders associated with oxidative stress-mediate
8                                          The renal disorder C3 glomerulopathy with dense deposit dise
9  respiratory disease, psychiatric disorders, renal disorders, cardiovascular disorders, and liver dis
10 oodpasture disease, an HLA-linked autoimmune renal disorder characterized by an immunodominant CD4(+)
11                  C3 glomerulopathy refers to renal disorders characterized by abnormal accumulation o
12            Cystic kidney diseases are common renal disorders characterized by the formation of fluid-
13 LDN19 function result in the inherited human renal disorder familial hypomagnesemia with hypercalciur
14 egmental glomerulosclerosis (FSGS), a common renal disorder in humans, and produce an apparent increa
15  conventional MGUS and assessed incidence of renal disorders in patients with light-chain MGUS.
16 e frequently called on to diagnose and treat renal disorders in pregnant women.
17 li seems to play a major role in a number of renal disorders, including glomerular diseases, ascribed
18 s a treatment not only for HIBM but also for renal disorders involving proteinuria and hematuria due
19 and 2.33), hydramnios (RRs = 2.04 and 1.66), renal disorders (RRs = 1.54 and 2.56), and intrapartum f
20  the cellular and molecular basis for cystic renal disorders should lead to specific intervention in
21 rodegenerative diseases, metabolic syndrome, renal disorders, skin disorders, and cancer.
22 ve been linked to the pathogenesis of cystic renal disorders such as autosomal dominant polycystic ki
23       SSSS in adults is also associated with renal disorders, suggesting that levels of toxin in seru
24 grade 3 disorders included hepatobiliary and renal disorders (three [13%] at 200 mg twice a day), ast
25 l conditions ranging from cardiovascular and renal disorders to fibrotic diseases.
26 merging as a viable therapeutic strategy for renal disorders with predominantly complement-driven eti

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。